AbstractHuman immunodeficiency virus type 1 (HIV-1) infection is initiated by successive interactions of viral envelope glycoprotein gp120 with two cellular surface proteins, CD4 and chemokine receptor. The two most common chemokine receptors that allow HIV-1 entry are the CCR5 and CXCR4. The CD4 and CCR5 are mainly localized to the particular plasma membrane microdomains, termed raft, which is rich in glycolipids and cholesterol. However, the CXCR4 is localized only partially to the raft region. Although the raft domain is suggested to participate in HIV-1 infection, its role in entry of CXCR4-tropic (X4-tropic) virus is still unclear. Here, we used a combination of CD4-independent infection system and cholesterol-depletion-inducing reagen...
For efficient entry into target cells, certain T cell-tropic HIV-1 isolates require both CD4 and the...
The identification of HIV-1 coreceptors has provided a molecular basis for the tropism of different ...
Development of an effective low-cost anti-acquired immunodeficiency syndrome (AIDS) drugs is needed ...
Human immunodeficiency virus type 1 (HIV-1) infection is initiated by successive interactions of vir...
AbstractHuman immunodeficiency virus type 1 (HIV-1) infection is initiated by successive interaction...
The contribution of raft domains to human immunodeficiency virus (HIV) 1 entry was assessed. In part...
Copyright © by The Rockefeller University PressHuman immunodeficiency virus (HIV)-1 infection depend...
The infection of CD4-negative cells by variants of tissue culture-adapted human immunodeficiency vir...
The human immunodeficiency virus type-1 (HIV-1) is the etiological agent of the acquired immunodefic...
Abstract Background HIV-1 entry into cells is a multifaceted process involving target cell CD4 and t...
AbstractMacrophages are an important natural target cell for HIV-1, but previous studies of virus en...
AbstractUsing a panel of chimeric viruses and their chimeric envelope glycoproteins, we have previou...
Human immunodeficiency virus (HIV) and simian (SIV) immunodeficiency virus entry is mediated by bind...
The human immunodeficiency virus type 1 (HIV-1) utilizes multiple cell surface molecules to mediate ...
AbstractThe Vpu protein of human immunodeficiency virus type 1 (HIV-1) is known to enhance virion re...
For efficient entry into target cells, certain T cell-tropic HIV-1 isolates require both CD4 and the...
The identification of HIV-1 coreceptors has provided a molecular basis for the tropism of different ...
Development of an effective low-cost anti-acquired immunodeficiency syndrome (AIDS) drugs is needed ...
Human immunodeficiency virus type 1 (HIV-1) infection is initiated by successive interactions of vir...
AbstractHuman immunodeficiency virus type 1 (HIV-1) infection is initiated by successive interaction...
The contribution of raft domains to human immunodeficiency virus (HIV) 1 entry was assessed. In part...
Copyright © by The Rockefeller University PressHuman immunodeficiency virus (HIV)-1 infection depend...
The infection of CD4-negative cells by variants of tissue culture-adapted human immunodeficiency vir...
The human immunodeficiency virus type-1 (HIV-1) is the etiological agent of the acquired immunodefic...
Abstract Background HIV-1 entry into cells is a multifaceted process involving target cell CD4 and t...
AbstractMacrophages are an important natural target cell for HIV-1, but previous studies of virus en...
AbstractUsing a panel of chimeric viruses and their chimeric envelope glycoproteins, we have previou...
Human immunodeficiency virus (HIV) and simian (SIV) immunodeficiency virus entry is mediated by bind...
The human immunodeficiency virus type 1 (HIV-1) utilizes multiple cell surface molecules to mediate ...
AbstractThe Vpu protein of human immunodeficiency virus type 1 (HIV-1) is known to enhance virion re...
For efficient entry into target cells, certain T cell-tropic HIV-1 isolates require both CD4 and the...
The identification of HIV-1 coreceptors has provided a molecular basis for the tropism of different ...
Development of an effective low-cost anti-acquired immunodeficiency syndrome (AIDS) drugs is needed ...